Jones Financial Companies
TENX icon

Jones Financial Companies’s Tenax Therapeutics TENX Stock Holding History

Jones Financial Companies’s Portfolio TENX Stock Details TENX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$15 Hold
1
– – ﹤0.01% 4694
2025
Q4 		$12 Hold
1
– – ﹤0.01% 4373
2025
Q3 		$7 Hold
1
– – ﹤0.01% 4214
2025
Q2 		$6 Buy
+1
New +$6 ﹤0.01% 4021

Other funds holding TENX

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
VCIM
Velan Capital Investment Management Alpharetta, Georgia $160M AUM 517.12% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Jones Financial Companies's TENX Position: Q1 2026 in Review

Jones Financial Companies held its Tenax Therapeutics (TENX) position steady in Q1 2026 at 1 share worth $15. The position accounts for ﹤0.01% of the portfolio, ranked #4694.

Jones Financial Companies first reported a position in TENX in Q2 2025 and has held it in 4 quarters since. 80 funds tracked by Wall St. Rank hold TENX as of Q1 2026.

  • Jones Financial Companies held 1 share of Tenax Therapeutics worth $15 as of Q1 2026.
  • Jones Financial Companies left its Tenax Therapeutics share count unchanged in Q1 2026.
  • Tenax Therapeutics made up ﹤0.01% of Jones Financial Companies's portfolio in Q1 2026, its #4694 holding.
  • Jones Financial Companies first reported a position in Tenax Therapeutics in Q2 2025 and has held it in 4 quarters since.
  • 80 funds tracked by Wall St. Rank held Tenax Therapeutics as of Q1 2026.

Based on Jones Financial Companies's 13F filing for Q1 2026, filed 15 May 2026.